home / stock / cbis / cbis news

CBIS News and Press, Cannabis Science Inc From 08/15/19

Stock Information
Company Name: Cannabis Science Inc
Stock Symbol: CBIS
Market: OTC
Menu
CBIS CBIS Quote CBIS Short CBIS News CBIS Articles CBIS Message Board
Get CBIS Alerts

News, Short Squeeze, Breakout and More Instantly...
CBIS - Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally

IRVINE, CA, Aug. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is preparing to announce a number of exciting new partnerships and acquisitions as the Company prepares for a ...
CBIS - Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

IRVINE, CA, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has successfully completed reorganization of its European business to bette...

CBIS - Cannabis Science, Inc. Successfully Completes Lab Testing for Its Proprietary, Short-Time Vacuum Distillation Process for Distribution of Purified High CBDA and CBD Water-Soluble Powders and Extracts Internationally

Laboratory Capacity Now Expands to Over 1,000 Kilograms Per Month of Purified High CBDA and CBD Water-Soluble Powders and Extracts for Full-Scale Product Development and Worldwide Wholesale Distribution  Irvine, CA - ( NewMediaWire ) - July 26, 2019 - Cannabis Science, Inc. (OTC:  C...

CBIS - Top Stocks that Could Benefit from USDA's Hemp Rules Rolling out in August 2019

July 11, 2019 Palm Beach, FL – July 11, 2019 – Hemp has a strong future thanks to the U.S. Farm Bill.  In fact, farmers across the U.S. have been rushing for a piece of the hemp market ever since President Trump signed the Farm Bill, which removed hemp from the ...
CBIS - 'Historic' reform hearing on marijuana

U.S. lawmakers weighed reforming pot laws in what advocates called a "historic” hearing on Wednesday, though there didn't appear to be a clear consensus approach, such as giving states the right for legalization, removing weed from schedule 1 of the Controlled Substances Act, or pro...

CBIS - Mr. Raymond C. Dabney Prepares Cannabis Science for the Next Level With Key Acquisitions Negotiated and Planned Mergers, a New Branding Splash, and a Black-Tie Dinner Awards Gala for the Ages

Acquisitions Designed to Complete the Company’s Financials, Introduce New Branding, and Hold Its 2019 CBIS Awards Gala to Thank the Company’s Shareholders and Stakeholders  IRVINE, CA, July 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (O...

CBIS - Cannabis Companies that Are Thriving thanks to 2018 U.S. Farm Bill

June 11, 2019 Palm Beach, FL – June 11, 2019 —  With the passage of the U.S. Farm Bill, hemp will see a significant catalyst for growth.  It’s already allowing for hemp cultivation and the transfer of hemp products across state lines for commercial a...
CBIS - CBIS Stock Down 4%: New Member Joins Scientific Advisory Board

While other cannabis companies focus on acquisitions and entering different markets, Cannabis Science (OTCPK:CBIS) continues to develop its clinical trial teams. Earlier today, the US company announced that it has appointed an influential member of the medical field to lead its cancer cli...

CBIS - Cannabis Science Propels Cancer Clinical Trials, Appoints Cellular Cancer Specialist Dr. Sulma Mohammed, Professor of Cancer Biology, Purdue University, to the Company's Scientific Advisory Board

IRVINE, CA, June 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the appointment of Dr. Sulma Mohammed, Professor of Cancer Biology at Purdue Uni...

CBIS - GHC Summit at Harvard Medical School Announces Cannabis Science as Industry Partner in the Launch of the International Phytomedicines Institute at Harvard Medical School

IRVINE, CA, May 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the research and development of cannabinoid-based medicines, is proud to announce it has been introduced as one of the key industry partners i...
Previous 10 Next 10